Fibroblastic and myofibroblastic tumors of the skin


Benign fibroblastic and myofibroblastic tumors

Hypertrophic Scar

Definition

  • A reactive proliferation of fibroblasts/myofibroblasts confined to the boundaries of the wound forming short fascicles, whorls, or nodules, typically lacking keloidal collagen

  • Generally associated with previous local trauma or burns

Clinical features

Epidemiology

  • Most commonly occurs in the second decade of life

  • Incidence after surgery from 40% to 70%, after burns from 30% to 90%

  • Lesions developing in the background of burns have a higher incidence in children

  • Familial predisposition common

  • No racial predilection

Presentation

  • Predilection for chest, back, shoulders, buttocks, and knees

  • Slightly raised lesion of reddish discoloration

  • Generally not thicker than 2 mm

  • Remains confined within the boundaries of the wound

  • Occurs shortly after injury, generally within week(s), and usually flattens spontaneously within 1 to 2 years

  • Occasionally associated with pruritus and/or pain

  • Extensive lesions associated with limited mobility and possibly also contractions

Prognosis and treatment

  • Shows tendency to flatten and regresses over time

  • Recurrences after simple excision in up to 10%

Pathology

Histology

  • Fascicles, whorls, and/or nodules composed of spindle-shaped fibroblasts/myofibroblasts

    • Frequently arranged parallel to the epidermis

    • Generally more cellular than keloids

  • By definition no wiry (keloidal) collagen

  • Increased amounts of small blood vessels with frequent perpendicular orientation to the epidermis

  • The epidermis can be atrophic

  • A foreign body granulomatous reaction occasionally present

  • Early lesions characterized by (opposite features typical for late lesions)

    • Increased cellularity

    • Increased amount of inflammatory cell infiltrate

    • Numerous capillaries

Main differential diagnoses

  • Distinction from keloids can be difficult. In the latter, however, wiry collagen is present

  • Desmoid or superficial fibromatosis (on small biopsy)

Fig. 1, Hypertrophic scar.

Fig. 2, Hypertrophic scar.

Keloid

Definition

  • A reactive proliferation of fibroblasts/myofibroblasts extending beyond the confines of the wound, characterized by the presence of thick (wiry) collagen bundles frequently arranged in an irregular pattern

  • Predisposing conditions include skin incision, local trauma, various inflammatory skin conditions, and burns; spontaneous occurrence not uncommon

Clinical features

Epidemiology

  • Highest incidence in the second decade of life

  • More common in certain ethnic groups, including Asian, black, and Hispanic populations, with the incidence in these groups as high as 15% (in other races the incidence varies from 0.2% to 1%)

  • Familial predisposition common

  • Both autosomal-dominant and -recessive modes of inheritance reported

Presentation

  • Raised lesion, frequently associated with reddish discoloration

  • Painful and/or pruritic

  • Predilection for earlobes, shoulders, anterior chest (in particular presternal area), upper arm, and cheeks

  • Typically grows beyond the confines of the original wound

  • Develops months or even years after the initial injury, most commonly from 3 months to 1 year

  • Multiple lesions not uncommon

Prognosis and treatment

  • Does not regress over time

  • Resistant to various forms of treatment

  • High recurrence rate after simple surgical excision (50%–80%)

Pathology

Histology

  • Thick, eosinophilic, or “glassy” wiry hyalinized collagen bundles (e.g., keloidal collagen) arranged in a haphazard pattern represent the hallmark of the entity, but prominent in only up to 55% of cases

  • Keloidal collagen admixed with spindle-shaped fibroblasts forming whorls, nodules, or fascicles

  • Fibroblasts generally represent a minor component of the lesion

  • Mucinous degeneration can be seen

  • Additional discriminative features from hypertrophic scar

    • No flattening of the overlying epidermis

    • No fibrosis of the papillary dermis

    • Absence of vertically oriented blood vessels

    • Prominent disarray of fascicles/nodules

    • Presence of tonguelike advancing edge

    • Prominent fascialike hypocellular fibrous band in parallel with the epidermis, usually in the deeper aspects of the lesion

Main differential diagnoses

  • Distinction from hypertrophic scar may be difficult on histological grounds alone and in small biopsies

  • Desmoid or superficial fibromatosis (on small biopsy)

Fig. 1, Keloid.

Fig. 2, Keloid.

Fig. 3, Keloid.

Cerebriform Fibrous Proliferation (Proteus Syndrome)

Definition

  • A postnatal disproportionate overgrowth of different tissues associated with cutaneous and extracutaneous manifestations, including also predisposition to different tumors

  • Results from mosaicism for a mutation that is lethal in nonmosaic state

  • Mandatory (general) and specific criteria were proposed in 1999 by Biesecker et al. and are reproduced here from their seminal paper

  • Mandatory (general) criteria

    • Mosaic distribution of lesion

    • Progressive course

    • Sporadic occurrence

  • Specific criteria (group A, two from group B, or three from group C)

    • Group A

      • Connective tissue nevus

    • Group B

      • Epidermal nevus

      • Disproportionate growth (one or more)

        • Limbs

        • Skull (hyperostosis)

        • External auditory meatus (hyperostosis)

        • Vertebra (megalospondylodysplasia)

        • Viscera (spleen and/or thymus)

          • Specific tumors before the end of the second decade (either one)

            • Bilateral ovarian cystadenomas

            • Parotid monomorphic adenoma

    • Group C

      • Dysregulated adipose tissue (either one)

        • Lipomas

        • Regional absence of fat

          • Vascular malformations (one or more)

            • Capillary, venous, and/or lymphatic malformation

          • Facial phenotype

            • Dolihocephaly

            • Long face

            • Minor downslanting of palpebral fissures and/or minor ptosis

            • Low nasal bridge

            • Wide or anteverted nares

            • Open mouth at rest

  • Skin lesions in Proteus syndrome include

    • Cerebriform connective tissue nevi (distinctive of the entity)

    • Epidermal nevi

    • Vascular malformations

    • Lipomas

    • Partial lipohypoplasia

    • Dermal hypoplasia

Clinical features

Epidemiology

  • Rare disorder with about 200 patients reported in Europe and North America

  • More common in males

Presentation

  • Onset of skin lesions

    • Congenital or neonatal onset

      • Usually stable lesions with no or little expansion in the postnatal period

      • Epidermal nevus and vascular malformations

    • Delayed onset

      • Progressive growth in the postnatal period

      • Cerebriform connective tissue nevus and lipomas

  • Cerebriform connective tissue nevus

    • Well-demarcated plaque with rugged cerebriform appearance

    • Firm consistency

    • Predilection for soles (can be bilateral) and palms

    • Other locations much more uncommon, including chest, abdomen, and back

    • Lesions may be inapparent before the age of 2 years

  • Epidermal nevus

    • Flat-topped, brown, hyperkeratotic papules in linear arrangements along Blaschko lines

    • Soft consistency

    • Asymmetrical distribution with predilection for trunk and neck

  • Vascular malformation

    • Violaceous compressible masses

    • Predilection for trunk and lower extremities

  • Lipomas

    • Soft skin-colored nodules

    • Predilection for head, abdomen, groin, and legs

  • Partial lipohypoplasia

    • Generally presents as areas with reduced fat content, thus displaying accentuated bony contours

    • Usually restricted to one-half of the trunk or extremities

  • Dermal hypoplasia

    • Depressed reddish plaques

    • Usually associated with decreased subcutaneous fat and absence of hair

    • Lower extremities

Prognosis and treatment

  • Skin lesions associated with significant morbidity and can be disfiguring

  • Conservative treatment is preferable for nontumorous proliferations

Pathology

Histology

  • Connective tissue nevus

    • Highly collagenized connective tissue

  • Epidermal nevus

    • Hyper(ortho)keratosis, acanthosis, and papillomatosis

    • No adnexal hyperplasia

  • Vascular malformation

    • See corresponding chapter

  • Lipoma

    • See corresponding chapter

Immunohistochemistry/special stains

  • Noncontributory

Main differential diagnoses

  • Klippel–Trénaunay syndrome

  • Epidermal nevus syndrome

  • Bannayan–Riley–Ruvalcaba syndrome

  • Hemihyperplasia multiple lipomatosis syndrome

Fig. 1, Proteus syndrome.

Fig. 2, Proteus syndrome.

Fig. 3, Proteus syndrome.

Nodular Fasciitis

Definition

  • A clonal myofibroblastic proliferation with rearrangement of the USP6 locus located on chromosome 17p13, characterized by a proliferation of bland spindle cells growing in short and loosely arranged fascicles in the background of a myxoid or collagenous stroma

  • Associated with a nonrandom somatic mutation, yet distinguished by self-limiting growth and spontaneous regression

Clinical features

Epidemiology

  • Young to middle-aged adults from 20 to 40 years of age

  • No gender predilection

  • About 10% of lesions develop in children, with male predominance

Presentation

  • Solitary, rapidly growing swelling or nodule, developing in the course of a few weeks (up to 8 weeks)

  • Tenderness over the affected area, lesions can also be asymptomatic

  • Size usually less than 3 cm (ranges from 0.4 cm to 10 cm)

  • Predilection for the subcutaneous tissue, fascial planes, or, less often, skeletal muscle of the upper extremities, particularly volar aspects of the forearm, trunk, and head and neck (most common site in children)

  • Rare sites include intraarticular, visceral, oral cavity, maxillary sinus, and within a nerve

  • History of previous trauma in up to 20%

Prognosis and treatment

  • Benign self-limiting proliferation

  • Recurrences after simple excision most unusual

  • Spontaneous regression common (in a large study, almost 90% of lesions regressed spontaneously after fine needle aspiration biopsy was performed for diagnostic purposes)

Pathology

Histology

  • Well-delineated and nonencapsulated, margins occasionally more infiltrative

  • Bland myofibroblastic proliferation

    • Short, irregular, and intersecting bundles or fascicles

    • Less often loose storiform or haphazard pattern

    • Plump vesicular nuclei, a single small nucleolus

    • Eosinophilic cytoplasm

    • No or limited nuclear pleomorphism

    • Mitoses common (from 1 to 10 per 10 high-power fields)

    • Atypical mitoses absent

  • Myxoid or fibrous stroma with feathery microcystic appearance (“tissue culture–like”)

    • Variably abundant

    • Extravasated red blood cells

    • Focal frank hemorrhagic areas with hemosiderin deposition (more prominent in intraarticular locations)

    • Chronic inflammatory cell infiltrate, predominantly composed of lymphocytes, especially at the periphery of the lesion

    • Metaplastic bone rarely present

    • Stromal hyalinization (more prominent in intraarticular locations)

    • Thin, small blood vessels, frequently lined by prominent endothelial cells

    • Multinucleated giant cells

  • Early lesions

    • More cellular proliferation

    • Loose myxoid matrix

  • Older lesions

    • Less cellular, especially toward the center of the lesion with cystic degeneration

    • Collagenized and hyalinized matrix, occasionally with keloidal appearance

Immunohistochemistry/special stains

  • Not contributive, merely confirm fibroblastic/myofibroblastic differentiation

  • Strongly and diffusely positive for smooth muscle actin and often calponin

  • Variable positivity for muscle specific actin, and much more infrequently for desmin

  • Consistently negative for cytokeratins, S100 protein, and CD34

Genetic profile

  • Genomic rearrangement of the USP6 locus on chromosome 17p13 detected in over 90% of cases

    • t(17;22)(p13;q13) resulting in the fusion gene MYH9-USP6 most common

Main differential diagnoses

  • Desmoid fibromatosis

  • Leiomyosarcoma

  • Sarcoma, not otherwise specified (NOS)

Fig. 1, Nodular fasciitis.

Fig. 2, Nodular fasciitis.

Fig. 3, Nodular fasciitis.

Fig. 4, Nodular fasciitis.

Fig. 5, Nodular fasciitis.

Fig. 6, Nodular fasciitis.

Fig. 7, Nodular fasciitis.

Fig. 8, Nodular fasciitis.

Fig. 9, Nodular fasciitis.

Fig. 10, Nodular fasciitis.

Intradermal Nodular Fasciitis

Definition

  • A rare morphological variant of nodular fasciitis occurring exclusively or predominantly within the dermis

Clinical features

Epidemiology

  • No gender predominance

  • Third decade of life

Presentation

  • Solitary painless mass, rapidly growing

  • Rare superficial ulceration and bleeding

  • Size ranging from 0.5 cm to 5.5 cm (mean 1.3 cm)

  • Predilection for limbs and trunk, followed by the head and neck

Prognosis and treatment

  • Benign clinical course

  • No recurrences after complete excision

Pathology

Histology

  • Well-circumscribed, nonencapsulated proliferation in the dermis, with possible limited extension into the subcutis

  • Bland uniform spindle cells

    • Short intersecting bundles, focal storiform pattern

    • Elongated tapering nuclei, vesicular chromatin, small nucleoli

    • No significant cytological atypia or pleomorphism

    • Mitoses not uncommon (mean number of 2.5 mitoses per 10 high-power fields)

  • Myxoid to collagenous stroma

    • Prominent stromal hyalinization with keloid-like areas

    • Extravasation of red blood cells and hemosiderin deposition

    • Metaplastic ossification and calcification

    • Osteoclast-like multinucleated giant cells

    • Slitlike capillary network

    • Inflammatory cell infiltrate, usually composed of lymphocytes

  • Overlying epidermis frequently ulcerated

Immunohistochemistry/special stains

  • Smooth muscle actin diffusely and strongly positive

  • Negative for CD34, desmin, h-Caldesmon, S100 protein, and cytokeratins

Genetic profile

  • HSPle (17p13) rearrangement in most cases

Main differential diagnoses

  • Cellular fibrous histiocytoma

  • Myofibroma

  • Superficial angiomyxoma

Fig. 1, Intradermal nodular fasciitis.

Fig. 2, Intradermal nodular fasciitis.

Fig. 3, Intradermal nodular fasciitis.

Fasciitis Ossificans

Definition

  • A variant of nodular fasciitis characterized by intralesional metaplastic bone formation

  • Identical on morphological grounds to myositis ossificans, typically lacking zonation pattern

Clinical features

Epidemiology

  • No gender predilection

  • Young adults between 20 and 30 years of age

Presentation

  • Solitary lesion, well-circumscribed mainly in the superficial soft tissues

  • Predilection for upper and lower extremities

  • History of previous local trauma in up to 15% of cases

Prognosis and treatment

  • Benign clinical course

  • Complete excision curative

Pathology

Histology

  • Background features of nodular fasciitis (see earlier)

  • Trabeculae of osteoid and mature woven bone arranged in irregular pattern, lined by bland osteoblasts

  • Areas of chondroid differentiation and calcifications occasionally present

Immunohistochemistry/special stains

  • See nodular fasciitis

Genetic profile

  • HSPle (17p13) rearrangement in most cases

Main differential diagnoses

  • Myositis ossificans

  • Osteosarcoma

Fig. 1, Fasciitis ossificans.

Fig. 2, Fasciitis ossificans.

Periosteal (Cranial) Fasciitis

Definition

  • A variant of fasciitis arising in deep soft tissues of the scalp with possible intracranial extension

Clinical features

Epidemiology

  • Male predominance (M : F = 2 : 1), with reversal of the ratio and female predominance with increasing age

  • Almost exclusively in children, particularly infants

  • Mean age at presentation about 20 months

  • Congenital occurrence rare

Presentation

  • Rapidly growing firm mass of typically short duration (few weeks)

  • Involves the deep soft tissues of the scalp, including deep fascia, galea capitis, cranial periosteum, or fibromembranous covers of the sutures with occasional erosion of the underlying bone

  • Mean size of 2.5 to 3 cm

  • Extension into or through the skull bone with/without dural involvement possible

  • Pure intracranial lesions localized to dura mater rare, and as a rule do not involve brain

  • Association with previous trauma (5%–15%), irradiation or surgical procedure, causative relationship uncertain

  • A single case associated with familial adenomatous polyposis displaying germline APC mutation with additional acquired somatic nonsense APC mutation reported recently

Prognosis and treatment

  • Benign self-limiting proliferation

  • Spontaneous regression possible

  • Simple excision is the treatment of choice

  • Local recurrence in about 1%

Pathology

Histology

  • Well-circumscribed proliferation composed of spindle- and stellate-shaped cells in the background of variably myxoid stroma

  • Myofibroblastic proliferation

    • Short intersecting bundles or fascicles, focal storiform pattern

    • Normal mitoses not infrequent, atypical mitoses distinctly uncommon

    • Minimal nuclear atypia

    • Cellularity varies, can be prominent

  • Intervening stroma

    • Myxoid with typical “tissue culture–like” appearance or collagenous

    • Thick hyalinized collagen bundles can be prominent

    • Delicate capillary network

    • Areas of hemorrhage and/or hemosiderin deposition

    • Inflammatory cell infiltrate, usually at the periphery

    • Multinucleated giant cells absent or rare

    • Focal osseous metaplasia, exceptional

Immunohistochemistry/special stains

  • Smooth muscle actin and muscle specific actin positive

  • Negative for S100 protein, cytokeratins, desmin, CD34

  • A subsets of lesions display nuclear β-catenin positivity

Genetic profile

  • Relationship to nodular fasciitis is uncertain as HSPle (17p13) rearrangement is not routinely present

  • Activating mutation to CTNNB1 , the gene encoding β-catenin, has also been noted

Main differential diagnoses

  • Desmoid fibromatosis

  • Infantile fibrosarcoma

Fig. 1, Periosteal (cranial) fasciitis.

Fig. 2, Periosteal (cranial) fasciitis.

Fig. 3, Periosteal (cranial) fasciitis.

Proliferative Fasciitis

Definition

  • A variant of fasciitis characterized by infiltrative growth along the superficial fascial planes and connective tissue septa of the subcutis and distinguished histologically by an admixture of fibroblasts/myofibroblasts with ganglion-like cells

  • Likely to represent a superficial counterpart of proliferative myositis

Clinical features

Epidemiology

  • No gender predilection

  • Predilection for middle-aged adults in the sixth decade of life (mean age about 50 years)

  • Occurrence in children exceptional

Presentation

  • Solitary poorly demarcated mass or nodule in the subcutis

  • Metachronous appearance in the orbit and forearm recently reported

  • Rapid growth typical, with the majority of the lesions developing in 2 to 6 weeks

  • Firm on palpation, movable, and not attached to the overlying skin

  • Painful in 50% to 75%

  • Predilection for the upper extremities, particularly volar side of the forearm, followed by the lower extremities, trunk, and head and neck

  • The majority of lesions less than 3 cm in diameter

  • Association with previous local trauma in less than 20%, causative relationship uncertain

Prognosis and treatment

  • Benign self-limiting clinical course

  • Spontaneous regression possible

  • Conservative complete excision

  • Recurrences exceptional

Pathology

Histology

  • Poorly delineated proliferation in the superficial fascia, with frequent multifocal extension into the connective septa of the subcutis and, less frequently, into the underlying skeletal muscle

  • Exclusive intradermal occurrence recently reported

  • Two main components are spindle cells (myofibroblasts) and ganglion-like cells embedded in a variably myxoid or collagenous stroma

  • Spindle cell proliferation

    • Short intersecting bundles or fascicles, focal storiform pattern

    • Normal mitoses not infrequent, atypical mitoses distinctly uncommon

  • Ganglion-like cells

    • One or two large vesicular nuclei, multinucleated forms much more infrequent

    • Prominent nucleoli

    • Abundant basophilic cytoplasm, fibrillary to granular

    • Loosely arranged or forming small groups

  • Intervening stroma

    • Myxoid or collagenous with typical tissue culture appearance

    • Delicate capillary network

    • Areas of hemorrhage and/or hemosiderin deposition

    • Inflammatory cell infiltrate, usually at the periphery

    • Focal osseous metaplasia, exceptional

  • Unusual features of lesions developing in children

    • More circumscribed and less infiltrative growth

    • Increased cellularity

    • Predominance of ganglion-like giant cells

Immunohistochemistry/special stains

  • Spindle cells

    • Smooth muscle actin and muscle specific actin positive

    • Negative for S100 protein, cytokeratins, desmin, CD34

  • Ganglion-like cells

    • Variable positivity for CD68

Genetic profile

  • Diploid pattern of DNA flow cytometry

  • Relationship to nodular fasciitis is uncertain as HSPle (17p13) is not routinely rearranged

Main differential diagnoses

  • Proliferative myositis

  • Rhabdomyosarcoma

  • Sarcoma, not otherwise specified (NOS)

Fig. 1, Proliferative fasciitis.

Fig. 2, Proliferative fasciitis.

Fig. 3, Proliferative fasciitis.

Fig. 4, Proliferative fasciitis.

Intravascular Fasciitis

Definition

  • A rare variant of nodular fasciitis occurring within small to medium-sized veins and arteries

Clinical features

Epidemiology

  • Slight male predominance (M : F = 1.4 : 1)

  • Age distribution wide (from 6 months to 66 years)

  • The majority occur from the first to the third decade of life

Presentation

  • Solitary, slowly growing nodule or mass, occasionally sausage shaped and multilobular

  • Rapid growth in 2 to 3 weeks reported in rare cases

  • Nonpainful, associated with discomfort, tender or painful

  • Multiple lesions within the single area also reported

  • Size from 0.6 cm to 5 cm

  • Predilection for head and neck and upper extremity, followed by lower extremity and trunk

  • Additional sites include oral cavity and periocular soft tissue

  • Association with previous trauma and/or thrombosis exceptionally reported, causative relationship not clear

  • An exceptional case developing in a pregnant woman also reported

Prognosis and treatment

  • Benign clinical course

  • Complete excision curative

  • Recurrence possible, but unlikely

Pathology

Histology

  • Typical features of nodular fasciitis (for detailed description see corresponding chapter), featuring plump spindle cells arranged in short intersecting fascicles, focal storiform pattern, or exhibiting a more haphazard growth in the background of variably myxoid stroma

  • Small to medium-sized arteries and veins, larger vessels can also be affected

    • Localized within the subcutaneous tissue

    • Involvement of dermis and deeper soft tissue more infrequent

  • Intraluminal, intramural, or with possible extramural extension

  • Infiltrative borders with entrapment of neighboring structures, like perivascular connective tissue, skeletal muscle, and fascia, also rarely reported

  • Extension from the main vessel into smaller vessels at some distance, creating “satellite” lesions or nodules occasionally present

  • Multinucleated cells less frequent than in classical nodular fasciitis

Immunohistochemistry/special stains

  • Smooth muscle actin positive

  • Negative for S100 protein, cytokeratins, desmin, CD34, and CD31

Genetic profile

  • Given the rarity of this lesion, HSPle (17p13) rearrangement status, is not well studied

Main differential diagnoses

  • Intravascular pyogenic granuloma

  • Fibromuscular dysplasia

  • Sarcoma, not otherwise specified (NOS)

Fig. 1, Intravascular fasciitis.

Fig. 2, Intravascular fasciitis.

Proliferative Myositis

Definition

  • A reactive pseudosarcomatous proliferation of ganglion-like cells and spindle cells with fibroblastic/myofibroblastic differentiation between preserved skeletal muscle fibers forming a typical checkerboard-like growth pattern

  • Possibly related to local trauma

Clinical features

Epidemiology

  • Adult patients between 40 and 50 years of age

  • Occurrence in children very rare

  • Equal gender distribution

Presentation

  • Rapidly growing soft tissue mass

  • Asymptomatic, discomfort, pain

  • Predilection for the shoulder area, followed by the trunk, proximal extremities, and head and neck

  • Intraoral occurrence exceptional

Prognosis and treatment

  • Spontaneous regression without particular treatment possible

  • Recurrences after marginal/incomplete excision distinctly uncommon

Pathology

Histology

  • Poor circumscription at the periphery

  • Proliferation of spindle cells and ganglion-like cells within the skeletal muscle, growing in horizontal and vertical planes, resulting in a checkerboard growth pattern

  • Regular mitoses not uncommon in either component, atypical mitoses absent

  • Ganglion-like cells

    • Typically contain large nuclei, one or more prominent nucleoli, and abundant basophilic cytoplasm

    • Evenly or randomly distributed within the lesion

  • Degenerative changes of skeletal muscle cells

  • Myxoid to collagenous stroma, occasionally with areas of osseous or chondroid metaplasia and focal aggregates of mononuclear inflammatory cells

  • Lesions in children usually more cellular, with predominance of spindle cells, display nodular rather infiltrative growth, better delineation of the lesion, and can contain foci of necrosis

Immunohistochemistry/special stains

  • Spindle cells

    • Smooth muscle actin positive

    • Variable positivity for CD68

  • Ganglion-like cells

    • Variable positivity for CD68 and smooth muscle actin

    • Negative for neural markers

  • S100 protein and desmin negative

Genetic profile

  • Cytogenetic analysis of two cases revealed trisomy 2 and translocation t(6;14)

  • HSPle (17p13) rearrangement not documented in this lesion

Main differential diagnoses

  • Distinction from sarcoma can be difficult in small biopsies

Fig. 1, Proliferative myositis.

Fig. 2, Proliferative myositis.

Fig. 3, Proliferative myositis.

Fig. 4, Proliferative myositis.

Fig. 5, Proliferative myositis.

Fig. 6, Proliferative myositis.

Ischemic Fasciitis

Definition

  • A reactive proliferation typically displaying a zonal appearance with a central area of fibrinoid degeneration/necrosis surrounded by a peripheral area consisting of granulation tissue representing an admixture of fibroblasts, myofibroblasts, blood vessels, and inflammatory cells

  • Likely related to pressure-induced ischemic injury

  • Severely debilitated patients under increased risk

  • Development in otherwise healthy persons increasingly recognized

  • Also designated as atypical decubital fibroplasia

Clinical features

Epidemiology

  • Elderly patients in the eighth and ninth decades of life predominantly affected

  • Rare under the age of 50 years

  • Rare in children

  • Male predominance

Presentation

  • Solitary, painless, ill-defined mass, slowly growing

  • Surface ulceration generally lacking

  • Duration usually less than 6 months

  • Size varies from 1.3 to 10 cm (median size 4.7 cm)

  • Predilection for soft tissues overlying bony prominences or for sites of increased pressure points, most frequently areas over the sacrum, greater trochanter, shoulder area, buttocks, and posterior chest wall

  • An unusual location includes the vulvovaginal area

  • Deep subcutaneous tissue, with possible involvement of the dermis, or deeper structures including skeletal muscles, tendons, and fascia

  • Exclusive involvement of skeletal muscle exceptional

Prognosis and treatment

  • Simple excision usually curative

  • Recurrences uncommon, generally related to the persistence of the underlying cause (e.g., pressure-related local ischemia)

Pathology

Histology

  • Zonal pattern of proliferation

  • The central area consists of fibrinoid degeneration or necrosis with subsequent formation of pseudocystic spaces

  • The peripheral area is composed of granulation tissue, representing an admixture of

    • Spindled and more epithelioid cells with irregular hyperchromatic smudged nuclei, prominent basophilic nucleoli, rare normal mitoses, and variably abundant amphophilic (basophilic) cytoplasm

    • Large polygonal ganglion-like cells containing round, oval, or reniform hyperchromatic nuclei with prominent nucleoli, similar to the ones present in proliferative fasciitis

    • Vascular proliferation, frequently containing thrombosed vascular spaces

    • Mixed inflammatory cell infiltrate

  • Additional changes include edema, hemorrhage, deposition of hemosiderin, areas of myxoid degeneration, chondroid metaplasia, and fat necrosis/infarction

Immunohistochemistry/special stains

  • Generally noncontributory

  • Variable positivity for smooth muscle actin, desmin, and calponin

  • Consistently negative for cytokeratins and S100 protein

Genetic profile

  • HSPle (17p13) is not rearranged

Main differential diagnoses

  • Proliferative fasciitis

  • Proliferative myositis

  • Nodular fasciitis

  • Sarcomas of different histogenesis

Fig. 1, Ischemic fasciitis.

Fig. 2, Ischemic fasciitis.

Fig. 3, Ischemic fasciitis.

Fig. 4, Ischemic fasciitis.

Elastofibroma

Definition

  • A benign, most likely reactive/degenerative proliferation composed of fibroblasts admixed with abnormal elastic fibers displaying beaded or globular pattern, excessive collagen deposition, and mature fat.

  • The presence of cytogenetic abnormalities in some cases suggests that the process is neoplastic (see later)

Clinical features

Epidemiology

  • Female predominance (F : M = 4 : 1)

  • Elderly patients, usually in their sixth to seventh decade of life, or after

  • Rare in children

  • Familial occurrence possible, but rare

  • An autopsy study detected the presence of subclinical elastofibromatous changes in nearly 25% of women and in about 10% of men after the age of 55 years

Presentation

  • Poorly demarcated, slowly growing swelling or mass

  • Asymptomatic, but can also be associated with discomfort, pain, stiffness, limited mobility, and/or snapping of the scapula

  • Predilection for the infrascapular region (over 95%), in particular, the area between the thoracic wall, the serratus anterior, and the latissimus dorsi muscle

  • Often attached to the periosteum of the bones of the thoracic wall

  • Infrequent sites include oral cavity, gastrointestinal tract, orbit, intraspinal space, intraarticular location, neural foramen, ligamentum flavum, ischial tuberosity, greater trochanter, olecranon, chest wall, axilla, inguinal area, deltoid muscle, foot, and greater omentum

  • Bilateral occurrence in up to two-thirds of cases, either synchronous or metachronous

  • Multiple lesions at distant locations rare

  • Size from 5 to 10 cm

  • Checkerboard white-and-yellow pattern on cut surface due to entrapment of fat

Prognosis and treatment

  • Complete excision curative

  • Recurrences after incomplete or marginal excision in up to 10%

Pathology

Histology

  • Hypocellular proliferation of spindled or stellate-shaped fibroblasts

    • Lack of mitotic activity

    • Lack of cytological atypia

  • Broad bands of collagenized stroma

  • Enlarged, fragmented, and branched elastic fibers resulting in a beaded, globular/discoid or irregularly grained appearance represent the hallmark of the lesion

  • Interspersed streaks of mature fat in variable proportions

  • Inflammatory cell infiltrate generally absent

  • Myxoid degeneration

  • Formation of pseudocystic spaces

Immunohistochemistry/special stains/cytogenetics

  • Fibroblasts CD34 and factor XIIIa positive

  • Elastic fibers can be highlighted by van Gieson stain

Genetic profile

  • Clonal and nonclonal abnormalities mainly affecting chromosome 1 and 3, translocations involving chromosome 8 and 12, and gains of Xq detected in limited number of cases

Main differential diagnoses

  • Not usually relevant due to typical histological features, but nuchal fibroma or desmoplastic fibroblastoma might be considered

Fig. 1, Elastofibroma.

Fig. 2, Elastofibroma.

Fig. 3, Elastofibroma.

Fig. 4, Elastofibroma.

Dermatomyofibroma

Definition

  • A benign tumor characterized by a plaquelike proliferation of bundles or fascicles of bland myofibroblasts growing in parallel to the epidermis in the superficial parts of the lesion while turning to perpendicular growth in the subcutis, mainly along the connective tissue septa

  • Papillary dermis typically spared

Clinical features

Epidemiology

  • Female predominance, but pediatric occurrence appears to have nearly equal gender distribution

  • Most common in the fourth decade of life (mean age 30 years)

  • Presentation in infancy or early childhood rare

Presentation

  • Solitary, slowly growing, indurated plaque or nodule; however, linear and annular variants also described

  • Multiple lesions exceptionally present

  • Hypopigmented, skin-colored, or brown-red discoloration

  • Asymptomatic, occasionally painful

  • Size from 1.0 to 2.0 cm, giant variants larger than 10 cm also reported

  • Predilection for shoulder area, upper arm, axillary region, neck, and upper trunk

  • Pediatric lesion shows predilection for the neck area

Prognosis and treatment

  • Simple excision curative

  • No recurrences reported even after marginal or incomplete excision

Pathology

Histology

  • Involvement of the reticular dermis and/or subcutis, whereas the papillary dermis and occasionally also superficial parts of the reticular dermis are usually spared

  • Ill-defined, plaquelike proliferation with occasional formation of nodules

  • Cellularity can vary

  • Bundles and fascicles of bland spindle cells running in parallel to the epidermis, frequently associated with perpendicular growth into the subcutis along the septa

    • Uniform vesicular nuclei with tapering ends

    • Absence of cytological atypia

    • Mitoses absent or rare

    • Bland eosinophilic cytoplasm

  • Adnexal structures preserved

  • Elastic fibers may be increased and fragmented

  • Additional features

    • Extravasation of erythrocytes

    • Proliferation of capillaries

    • Formation of sievelike and slitlike spaces

    • Mild inflammatory cell infiltrate

  • Overlying epidermis normal, but can also be hyperplastic or, rarely, atrophic

Immunohistochemistry/special stains

  • Variable positivity for smooth muscle actin, calponin, and muscle specific actin

  • In some cases smooth muscle actin can be negative

  • Focal positivity for CD34 not uncommon, but never diffuse

  • Desmin, h-Caldesmon, S100 protein, β-catenin, EMA, and markers of epithelial differentiation consistently negative

Main differential diagnoses

  • Dermatofibroma

  • Pilar leiomyoma

  • Neurofibroma

  • Dermatofibrosarcoma protuberans

Fig. 1, Dermatomyofibroma.

Fig. 2, Dermatomyofibroma.

Fig. 3, Dermatomyofibroma.

Fig. 4, Dermatomyofibroma.

Fig. 5, Dermatomyofibroma.

Superficial Acral Fibromyxoma

Definition

  • A benign tumor composed of spindled and stellate-shaped fibroblast-like cells growing in a haphazard, storiform, or vague fascicular pattern, set in the background of myxoid, fibromyxoid, or collagenous stroma

  • Also referred to as digital fibromyxoma

Clinical features

Epidemiology

  • Male predominance (M : F = about 2 : 1)

  • Adult patients, most commonly around 50 years of age

Presentation

  • Solitary

  • Slowly growing mass

  • The majority of lesions are smaller than 2 cm in greatest diameter

  • Asymptomatic (about 50%), tender, or painful

  • Destruction of nail plate not uncommon

  • Striking predilection for fingers, particularly subungual or periungual area of the hands and feet

  • Occurrence outside acral locations an exception

  • Previous local trauma in a minority of cases, pathogenetic role not clear

Prognosis and treatment

  • Complete excision curative

  • Recurrences after marginal or incomplete excision in up to 25%

Pathology

Histology

  • Centered predominantly in the dermis, with possible extension into subcutis

  • Involvement of deeper structures, including fascia, periosteal surface, and bone, rare

  • Margins infiltrative and poorly delineated or expansile and well circumscribed

  • Spindled and stellate cells arranged in haphazard, loose storiform or vague fascicular growth pattern

    • No or mild nuclear atypia in the majority of cases

    • Focal areas or scattered cells with moderate to severe nuclear atypia and pleomorphism found in rare cases, thought to be degenerative in nature (enlarged nuclei with irregular contours, hyperchromasia, clumped chromatin, and indistinct nucleoli)

    • Mitoses rare (fewer than 1 per 10 high-power fields), absence of atypical mitoses

    • Pale eosinophilic cytoplasm

  • Multinucleated giant cells (present in about 50%)

  • Predominantly myxoid, myxocollagenous, or predominantly collagenous stroma/matrix

  • Vascular proliferation and increased number of mast cells, particularly in myxoid areas

  • Chondroid and osseous metaplasia rare

Immunohistochemistry/special stains

  • CD34 positive

  • Variable positivity for EMA

  • Generally negative for cytokeratins, S100 protein, desmin, glial fibrilary acid protein, MUC4, claudin-1

Genetic profile

  • Loss of RB1 (13q14)

  • Spindle cell lipoma, pleomorphic lipoma, mammary-type myofibroblastoma, and cellular angiofibroma also show RB1 loss

Main differential diagnoses

  • Acquired digital fibrokeratoma

  • Periungual/subungual fibroma

  • Cellular myxoma

  • Superficial angiomyxoma

  • Low-grade fibromyxoid sarcoma

  • Dermatofibrosarcoma protuberans

Fig. 1, Superficial acral fibromyxoma.

Fig. 2, Superficial acral fibromyxoma.

Fig. 3, Superficial acral fibromyxoma.

Fig. 4, Superficial acral fibromyxoma.

Fig. 5, Superficial acral fibromyxoma.

Fig. 6, Superficial acral fibromyxoma.

Fibroepithelial Polyp

Definition

  • A very common lesion, composed of fibrovascular core, covered by normal or acanthotic epidermis

  • Also designated acrochordon, skin tag, or soft fibroma (e.g., fibroma mole)

Clinical features

Epidemiology

  • Adult patients

  • Female predominance

  • Multiple lesions can be associated with pregnancy, obesity, diabetes, and Birt–Hogg–Dube syndrome

  • Lesions in children extremely rare, and when present can signify association with nevoid basal cell carcinoma syndrome

Presentation

  • Polypoid or pedunculated lesion

  • Skin colored or hyperpigmented

  • Size from 0.2 to 5 cm (on average less than 1 cm)

  • Multiple lesions frequent, developing either synchronously or metachronously

  • Predilection for skin folds of the neck, axilla and groins, and perianal and genital area; other locations much more infrequent

Prognosis and treatment

  • Benign proliferation

  • Simple excision generally curative, most commonly performed due to cosmetic reasons

  • Isolated cases of basal cell carcinoma, squamous cell carcinoma in situ, and invasive squamous cell carcinoma described histologically in the background of a clinically banal fibroepithelial polyp

Pathology

Histology

  • Lesion generally covered by normal or hyperplastic epidermis

  • Fibrovascular core containing loose or dense collagen fibers

  • Lack of skin adnexa within the lesion

  • Mature fat occasionally abundant

    • Overlapping features with nevus lipomatosus superficialis

  • Lesions containing scattered cells with bizarre hyperchromatic nuclei and multinucleated giant cells also referred to as pleomorphic fibromas (see p. 82 )

Immunohistochemistry/special stains

  • Not contributory

  • The bizarre cells in pleomorphic fibroma may be smooth muscle actin positive

Main differential diagnoses

  • Polypoid seborrheic keratosis

  • Intradermal lipoma

Fig. 1, Fibroepithelial polyp.

Fig. 2, Fibroepithelial polyp.

Sclerotic Fibroma

Definition

  • A benign nodular fibroblastic proliferation composed of thick collagen bundles arranged in storiform or whorled pattern, reminiscent of plywood, separated by artifactual clefts and containing scattered spindled or stellate-shaped fibroblasts

  • Multiple cutaneous lesions, in addition to or without oral mucosal lesions, represent a hallmark of Cowden syndrome

    • An autosomal-dominant disorder caused by germline mutations in the PTEN gene

    • Associated with increased risk of visceral malignancies, particularly breast (often bilateral), thyroid, and endometrial carcinoma

    • Solitary lesions can also be associated with Cowden syndrome, albeit much more infrequently

  • Alternatively designated storiform collagenoma

  • Giant cell collagenoma represents a distinctive subtype and is generally not associated with Cowden syndrome

Clinical features

Epidemiology

  • No gender predominance

  • All age groups can be affected, including children

Presentation

  • Slow-growing, skin-colored or erythematous papule or nodule

  • Firm on palpation, asymptomatic

  • Solitary lesion or multiple occurrence

  • Size up to 1 cm

  • No site predilection

Prognosis and treatment

  • Complete excision curative

  • Recurrences distinctly uncommon

Pathology

Histology

  • Papillary dermis frequently unaffected

  • Well-circumscribed, nonencapsulated hypocellular proliferation in the dermis

  • Thick collagen bundles arranged in a storiform or whorled pattern

  • Collagen bundles separated by prominent artifactual clefts

  • Cleftlike spaces may contain copious amounts of mucin

  • Scattered spindled or stellate-shaped fibroblasts among collagen bundles, with no or with mild nuclear pleomorphism and absence of mitotic activity

  • Multinucleated giant cells occasionally present, dispersed among collagen bundles

    • Defining feature of giant cell collagenoma (regarded as a subtype of sclerotic fibroma)

    • Foreign body type, Touton type, Langhans type, and/or floretlike

    • Bizarre-shaped, crowded vesicular nuclei, frequently overlapping

    • Small prominent nucleoli

    • Mitoses generally absent

    • Pale cytoplasm

  • Absence of elastic fibers and adnexal structures within the lesion

  • Epidermis overlying the lesion usually atrophic

Immunohistochemistry/special stains

  • CD34 and CD99 positive

  • Consistently negative for smooth muscle actin, desmin, calponin, S100 protein, and EMA

Main differential diagnoses

  • Sclerotic fibroma-like pattern in inflammatory lesions, for example, folliculitis, chronic fibrosing vasculopathy (erythema elevatum diutinum)

  • Sclerotic fibroma-like pattern in various neoplastic lesions, including dermatofibroma, neurofibroma, melanocytic nevus, lipoma, fibroma of tendon sheath, angiofibroma

Fig. 1, Sclerotic fibroma.

Fig. 2, Sclerotic fibroma.

Fig. 3, Sclerotic fibroma.

Fig. 4, Sclerotic fibroma.

Pleomorphic Fibroma

Definition

  • A benign hypocellular proliferation composed of spindle-shaped, stellate, epithelioid, and multinucleated fibroblasts/myofibroblasts with variable degenerative atypia amid the background of haphazardly arranged collagen bundles

Clinical features

Epidemiology

  • Middle-aged and older adults (sixth decade of life)

  • Male predominance

Presentation

  • Solitary

  • Polypoid or dome-shaped papule

  • Predilection for extremities and trunk, followed by the head and neck area

Prognosis and treatment

  • Complete excision curative

  • Recurrences after incomplete excision very rare

Pathology

Histology

  • Well-circumscribed, nonencapsulated, hypocellular dermal proliferation

  • Spindle-shaped, stellate, epithelioid, and multinucleated (often floretlike) giant cells with degenerative atypia

    • Large pleomorphic hyperchromatic nuclei and small nucleoli

    • Mitotic activity absent or infrequent, yet atypical mitoses occasionally seen

  • Thick and haphazardly arranged collagen bundles with slitlike spaces

  • Additional features

    • Mature adipose tissue, likely the results of metaplastic change

    • Stroma with areas of hyalinization, sclerosis, and/or myxoid degeneration

    • Inflammatory cell infiltrate, composed of lymphocytes and histiocytes

    • Dilated blood vessels with or without areas of hemorrhage

Immunohistochemistry/special stains

  • Inconsistent positivity for smooth muscle actin, muscle specific actin, factor XIIIa, and CD34

Main differential diagnoses

  • Sclerotic fibroma (likely represents part of a spectrum)

  • Giant cell collagenoma

  • Atypical fibrous histiocytoma

  • Giant cell fibroblastoma

Fig. 1, Pleomorphic fibroma.

Fig. 2, Pleomorphic fibroma.

Fig. 3, Pleomorphic fibroma.

Fig. 4, Pleomorphic fibroma.

Fig. 5, Pleomorphic fibroma.

Fig. 6, Pleomorphic fibroma.

Fig. 7, Pleomorphic fibroma.

Fig. 8, Pleomorphic fibroma.

Nuchal Fibroma

Definition

  • A paucicellular, reactive proliferation composed of thick and haphazardly arranged collagen fibers, without significant increase in the number of fibroblasts, typically containing entrapped lobules of mature fat, peripheral nerve endings, and traumatic neuroma-like nerve proliferation

  • Designated also as collagenosis nuchae

  • Lesions at extranuchal sites alternatively designated as nuchal-type fibromas

  • Fibroblastic proliferation(s) in Gardner syndrome, also called Gardner-associated fibroma(s) or Gardner fibroma, essentially indistinguishable from nuchal fibroma on histological grounds

Clinical features

Epidemiology

  • Male predominance

  • Nuchal fibromas generally occur in adult patients (mean age about 40 years)

  • Extranuchal fibromas tend to develop at younger age (mean age 25 years)

  • Occurrence in children should raise the suspicion of Gardner fibroma in the background of Gardner syndrome

Presentation

  • Solitary, poorly circumscribed, ill-defined mass

  • Multiple lesions exceptionally present, either within the same topographical area or at distant sites

  • Asymptomatic, mild discomfort or pain

  • Nuchal fibromas tend to be smaller (mean diameter about 4 cm) than extranuchal fibromas (mean diameter 6 cm)

  • Predilection for posterior neck, interscapular, and paraspinal areas

  • Extranuchal locations in about one-third, including back, shoulder, face, buttock, and extremities

  • Associated conditions include diabetes mellitus (up to 50%), previous local trauma, and much more infrequently scleroderma and scleredema

  • Collision with dermatofibrosarcoma protuberans reported in an exceptional case, likely coincidental

  • Generally not associated with familial adenomatous polyposis or desmoids tumors (in contrast to Gardner fibroma)

Prognosis and treatment

  • Complete excision curative

  • Nondestructive recurrences in over 40% at extranuchal sites

Pathology

Histology

  • Predominantly centered in the subcutaneous fatty tissue

  • Extension into the dermis not uncommon, whereas involvement of skeletal muscle(s) or deeper structures rare

  • Paucicellular proliferation

  • Thick collagen bundles arranged in haphazard pattern, but vague lobular arrangement can be appreciated toward the center of the lesion

  • Cracking artifacts between collagen bundles

  • Scattered fibroblasts between collagen bundles

  • Entrapment of lobules of mature fat and nerve endings typical for the entity, but skin adnexa can also be entrapped

  • Traumatic neuroma-like proliferation of small nerves frequently present

  • Perineural fibrosis occasionally present

  • Number of elastic fibers within the lesion typically reduced

  • Mild inflammatory cell infiltrate, composed of lymphocytes, occasionally present

Immunohistochemistry/special stains

  • CD34 (up to 80%) and CD99 positive

  • Negative for smooth muscle actin, β-catenin, desmin, S100 protein

Main differential diagnoses

  • Gardner fibroma

  • Connective tissue nevus

  • Desmoid-type fibromatosis

Fig. 1, Nuchal fibroma.

Fig. 2, Nuchal fibroma.

Fig. 3, Nuchal fibroma.

Fig. 4, Nuchal fibroma.

Gardner Fibroma

Definition

  • A paucicellular fibroblastic proliferation, composed of haphazardly arranged thick collagen bundles separated by cracks, containing sparse spindled fibroblasts and entrapped fat lobules and nerve fibers, especially at the periphery

  • Indistinguishable histologically from nuchal fibroma

  • Of paramount importance due to its association with familial adenomatous polyposis (FAP)

    • Detected in almost 70% of FAP patients in a recent study, but this can be an underestimate due to the lack of familial history, a new APC mutation, sporadic occurrence, or

    • Can represent an initial manifestation of Gardner syndrome

  • About 10% of patients with Gardner fibroma have familial history of desmoid fibromatosis

  • Gardner syndrome

    • A subtype of familial adenomatous polyposis, an autosomal dominantly inherited condition due to mutation(s) in the APC gene

    • Multiple colonic adenomas with 100% risk of malignant transformation if left untreated

    • Extracolonic manifestations include, among others, fibromas, desmoid fibromatosis, epidermal inclusion cysts, osteomas, fibrous dysplasia of the skull, supernumerary teeth, and thyroid carcinoma

Clinical features

Epidemiology

  • Children and young adults

  • About 30% diagnosed in the first year, almost 80% in the first decade, 15% in the second decade, and less than 10% after the third decade

  • Slightly more common in males (M : F = 1.2 : 1)

Presentation

  • Slowly growing, ill-defined plaque of rubbery consistency

  • Solitary lesions more common than multifocal tumors (concurrent or subsequent)

  • Size from 0.3 to 12 cm (mean size 3.9 cm)

  • Most frequently on the back and paraspinal region (78%), followed by the head and neck area (14%), extremities (14%), and chest/abdomen (11%)

Prognosis and treatment

  • Benign behavior

  • Concurrent or subsequent development of desmoid fibromatosis with or without prior precipitating factor (trauma and/or surgery) in about 20% of cases

Pathology

Histology

  • Poorly circumscribed proliferation in the superficial (subcutis/dermis) and/or deep soft tissue (deeper to the fascia with skeletal muscle involvement)

  • Hypocellular proliferation

  • Haphazardly arranged thick collagen bundles often associated with cracking artifact

  • Spindled or fusiform fibroblasts scattered between collagen bundles

  • Small capillary-sized blood vessels between collagen bundles, frequently compressed

  • Entrapment of fat lobules and peripheral nerve fibers, especially at the periphery

  • Lack of nodularity and fascicular growth

  • Increased number of small nerve twigs/bundles (traumatic neuroma-like), as in nuchal fibroma, usually not present

  • Can be associated with desmoid fibromatosis, characterized by fascicular growth and more prominent cellularity (see corresponding chapter)

Immunohistochemistry/special stains

  • Positive for CD34, cyclin D1, and c-Myc

  • Variable β-catenin nuclear positivity (in about 70% of cases)

  • Negative for smooth muscle actin, desmin

Main differential diagnoses

  • Nuchal fibroma

  • Desmoid fibromatosis

Fig. 1, Gardner fibroma.

Fig. 2, Gardner fibroma.

Fig. 3, Gardner fibroma.

Nuchal Fibrocartilaginous Pseudotumor

Definition

  • A reactive/reparative lesion within the nuchal ligament composed of nodular proliferation of fibroblasts and mature cartilage, representing a metaplastic fibrocartilaginous process

  • Usually associated with previous local trauma or chronic mechanical stress

  • Degenerative process (e.g., arthritis or arthropathy) can alternatively contribute to the development of the lesion in a minority of cases

  • An identical lesion recently reported on the plantar foot

Clinical features

Epidemiology

  • Equal gender distribution

  • Adult patients in the third to fifth decade of life

  • Lesions in children extremely rare, generally trauma related

Presentation

  • Slowly growing mass or nodule

  • Poorly delineated

  • Asymptomatic, associated with stiffness or painful

  • Size generally less than 3 cm in greatest diameter

  • Localized within the nuchal ligament; surrounding structures can also be affected

  • Predilection for the deep soft tissue of the lower cervical spine at the junction of nuchal ligament and deep cervical fascia at the level of C4–5 and C5–6

Prognosis and treatment

  • Complete excision curative

  • No recurrences reported after complete excision

Pathology

Histology

  • Poorly delineated and moderately cellular proliferation of fibroblasts and chondroblasts forming a nodule

  • Both cellular components fairly uniform, lacking cytological atypia(s), nucleoli, and mitotic activity

  • Chondroblasts frequently arranged in short cords or strands, binucleated cells within lacunae generally absent

  • Fibroblastic component often paucicellular

  • Disorganization of collagen and fragmentation of elastic fibers within the lesion

  • Inflammation, hemorrhage, or deposition of hemosiderin generally absent

  • Degenerative changes of the nuchal ligament surrounding the central area of fibrochondrous metaplasia with fragmentation of elastic fibers

Immunohistochemistry/special stains

  • CD34 positivity in both fibroblastic and chondroblastic component

  • Chondroid areas display S100 protein positivity

  • Negative for desmin and CD99

Main differential diagnoses

  • Soft tissue chondroma

  • Nuchal fibroma

  • Myositis ossificans

Fig. 1, Nuchal fibrocartilaginous pseudotumor.

Fig. 2, Nuchal fibrocartilaginous pseudotumor.

Fibromatosis Colli

Definition

  • A reactive paucicellular proliferation of fibroblasts embedded in collagenous stroma within the sternocleidomastoid muscle resulting in shortage and lack of contractility of the muscle

  • Also designated as sternocleidomastoid tumor of infancy or congenital torticollis

  • Possibly related to trauma of the affected region at birth, ischemia, or intrauterine malposition; the exact pathogenesis is still unknown

Clinical features

Epidemiology

  • Incidence of 0.4% live births

  • Slight male predominance (M : F = 1.5 : 1)

  • Over 90% of the lesions present before the age of 3 months, usually between first and eighth week of life

  • Delayed presentation in adults has been reported

  • Familial occurrence in less than 5% with possible autosomal-dominant pattern of inheritance

Presentation

  • Nontender, firm, fusiform swelling within the sternocleidomastoid muscle

  • Initial rapid growth for several weeks, followed by stabilization of the lesion with lack of additional growth lasting for several months, with subsequent spontaneous diminution or complete regression of the lesion within the first year of life

  • Nodular proliferation can be associated with ipsilateral tilting of the head and contralateral head rotation (e.g., torticollis) in about 20% to 25%

  • The lesion typically measures between 1 and 3 cm in diameter

  • The majority of the lesions are solitary, bilateral occurrence being exceptional

  • Overlying skin generally normal; hyperpigmentation and hypertrichosis reported in a single case

Prognosis and treatment

  • Spontaneous resolution in 50% to 80%, usually within the first year

  • Initial treatment should be conservative, including physical therapy, heat, and massage

  • Surgical therapy (usually in less than 10%) restricted for lesions nonresponsive to conservative treatment

  • Late complications include delayed torticollis and craniofacial asymmetry

Pathology

Histology

  • Proliferation of bland spindled fibroblasts associated with variable amount of collagenous matrix between skeletal muscles with replacement of skeletal muscles resulting in the formation of predominantly hypocellular collagenous mass

  • Skeletal muscles frequently atrophic with accompanying degenerative changes

  • Inflammatory cell infiltrate generally absent

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here